Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Heart Failure Clinics
|
September 5, 2020
Transitioning Patients with Heart Failure to Outpatient Care
R Kannan Mutharasan
JACC. Advances
|
July 26, 2024
Population Health and Artificial Intelligence
R Kannan Mutharasan, Jessica Walradt
JAMA
|
February 19, 2020
Aspirin for Prevention of Cardiovascular Disease
Andrew T Peters, R Kannan Mutharasan
Heart Failure Clinics
|
September 5, 2020
The Critical Need for Process Improvement in Heart Failure
Clyde W Yancy, R Kannan Mutharasan, Eduardo Bossone
Journal of Materials Chemistry. B
|
April 13, 2016
High-Density Lipoproteins for Therapeutic Delivery Systems
R Kannan Mutharasan, Linda Foit, C Shad Thaxton
Circulation Research
|
February 2, 2008
The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel
Michael A Burke, R Kannan Mutharasan, Hossein Ardehali
Heart Failure Clinics
|
September 5, 2020
Approaching Process Improvement
Itai Gurvich, R Kannan Mutharasan, Jan Albert Van Mieghem
American Journal of Physiology. Heart and Circulatory Physiology
|
August 16, 2011
microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects
R Kannan Mutharasan, Varun Nagpal, Yoshihiko Ichikawa, et al.
Frontiers in Cardiovascular Medicine
|
March 18, 2017
High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease
Mazen S Albaghdadi, Zheng Wang, Ying Gao, et al.
Journal of the American Heart Association
|
April 24, 2013
MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes
Aijun Qiao, Arineh Khechaduri, R Kannan Mutharasan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Heart Failure Clinics
|
September 5, 2020
Transitioning Patients with Heart Failure to Outpatient Care
R Kannan Mutharasan
JACC. Advances
|
July 26, 2024
Population Health and Artificial Intelligence
R Kannan Mutharasan, Jessica Walradt
JAMA
|
February 19, 2020
Aspirin for Prevention of Cardiovascular Disease
Andrew T Peters, R Kannan Mutharasan
Heart Failure Clinics
|
September 5, 2020
The Critical Need for Process Improvement in Heart Failure
Clyde W Yancy, R Kannan Mutharasan, Eduardo Bossone
Journal of Materials Chemistry. B
|
April 13, 2016
High-Density Lipoproteins for Therapeutic Delivery Systems
R Kannan Mutharasan, Linda Foit, C Shad Thaxton
Circulation Research
|
February 2, 2008
The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel
Michael A Burke, R Kannan Mutharasan, Hossein Ardehali
Heart Failure Clinics
|
September 5, 2020
Approaching Process Improvement
Itai Gurvich, R Kannan Mutharasan, Jan Albert Van Mieghem
American Journal of Physiology. Heart and Circulatory Physiology
|
August 16, 2011
microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects
R Kannan Mutharasan, Varun Nagpal, Yoshihiko Ichikawa, et al.
Frontiers in Cardiovascular Medicine
|
March 18, 2017
High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease
Mazen S Albaghdadi, Zheng Wang, Ying Gao, et al.
Journal of the American Heart Association
|
April 24, 2013
MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes
Aijun Qiao, Arineh Khechaduri, R Kannan Mutharasan, et al.
Page
of 4